Abstract
The cardiac inotropic agents are substances that modify cardiac muscle contraction by acting directly on the myocardium (1). These agents could be categorized into two major classes; positive inotropic agents that stimulate cardiac muscle contraction such as the cardiac glycosides (2), the catecholamines (3) and the bipyridines (4), and negative inotropic agents that depress cardiac contraction such as the β-adrenergic blockers, the antiarrhythmics and the barbiturates (5).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alousi, A.A. and Farah, A.E., Trend Pharmacol. Sci. 1: 143–146, 1980.
Grupp, G., Grupp, I.L., Hickerson, T., Lee, S.W. and Schwartz, A. In: Cardiac Glycosides 1785-1985. (Eds. E. Erdmann, K. Greef and J.C. Skou), Stinkopff Verlag Darmstadt, Springer-Verlag, New York, 1986, pp. 99–108.
Scholtz, H. In: Handbook of Experimental Pharmacology, Adrenergic Activators and Inhibitors, (Ed. L. Szekeres), Springer-Verlag, Berlin/ Heidelberg/New York, 54(1): 651–733, 1980.
Alousi, A.A., Fabian, R.J., Baker, J.F. and Stroshane, R.M. In: New Drugs Annual: Cardiovascular Drugs (Ed. A. Scriabine), Raven Press, New York, 3:245–283, 1985.
Alousi, A.A., Canter, J.M. and Fort, D.J. Cardiovas. Res. 19: 483–494, 1985.
Braunwald, E. In: Heart Disease (Ed. E. Braunwald), W.B. Saunders Comp., Philadelphia, London, Toronto, 1984, pp. 453–471.
Colucci, W.S., Wright, R.F. and Braunwald, E. New. Engl. J. Med. 314: 349–358, 1986.
Goldberg, L.I. Pharmacol. Rev. 24: 1–29, 1972.
Tuttle, R.R., Mills, J. Circ. Res. 36: 185–196, 1975.
Katz, A. In: Physiology of the Heart (Ed. A. Katz), Raven Press, 1977, pp. 107–119.
Stull, J.T. and Mayer, S.E. In: Handbook of Physiology, The Cardiovascular System, Vol. I. The Heart. (Eds. R.M. Berne, N. Sperelakis and S.R. Geiger). The Physiological Soc., Bethesda, Maryland, 1979, pp. 741–774.
Ruegg, J.C. Cir. Res. Supp. 73: III, 78–84, 1986.
Hoh, J.F.Y., McGrath, P.A. and Hale, P.T. J. Mol. Cell. Cardiol. 10: 1053–1076, 1978.
Pagani, E.D. and Julian, F.J. Circ. Res. 54: 586–594, 1984.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Martinus Nijhoff Publishing, Boston
About this chapter
Cite this chapter
Alousi, A.A. (1987). Classification and Mechanism of Action of the Cardiac Inotropic Agents: An Overview. In: Beamish, R.E., Panagia, V., Dhalla, N.S. (eds) Pharmacological Aspects of Heart Disease. Developments in Cardiovascular Medicine, vol 68. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2057-9_26
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2057-9_26
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9222-7
Online ISBN: 978-1-4613-2057-9
eBook Packages: Springer Book Archive